What is plateau pressure and what is the recommended maximum value for adult mechanically ventilated patients, particularly those with acute respiratory distress syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Plateau Pressure in Mechanical Ventilation

Plateau pressure is the pressure measured during an inspiratory pause when there is no airflow, reflecting alveolar pressure and lung compliance; for adult mechanically ventilated patients with ARDS, the maximum plateau pressure should be kept at or below 30 cm H₂O.

Definition and Clinical Significance

Plateau pressure (Pplat) represents the static pressure in the airways and alveoli at end-inspiration when airflow has ceased. This measurement is obtained by applying an inspiratory hold maneuver (typically 0.5-1 second) on the ventilator. Unlike peak inspiratory pressure, which includes resistance from the airways and endotracheal tube, plateau pressure specifically reflects:

  • Alveolar distending pressure
  • Lung and chest wall compliance
  • Risk of ventilator-induced lung injury (VILI)

Recommended Maximum Value

The guideline-recommended upper limit is ≤30 cm H₂O for all patients with ARDS 1. This represents a strong recommendation with moderate confidence in effect estimates from the American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine 2017 guidelines, which has been reaffirmed in the 2024 ATS update 2.

Evidence Base

The 30 cm H₂O threshold is derived from landmark trials demonstrating that lung-protective ventilation strategies combining:

  • Low tidal volumes (4-8 mL/kg predicted body weight)
  • Plateau pressure limitation to ≤30 cm H₂O

These strategies significantly reduce mortality and improve outcomes in ARDS patients 1.

Emerging Evidence on Lower Thresholds

Recent research suggests the optimal plateau pressure may actually be lower than 30 cm H₂O, particularly during the initial phase of mechanical ventilation:

  • A 2021 meta-regression analysis found that plateau pressures above 27 cm H₂O on day 1 of mechanical ventilation were associated with increased mortality 3
  • Plateau pressures above 32 cm H₂O during the first 3 days showed significantly higher short-term mortality 3
  • The association between plateau pressure and mortality was strongest during the initial period and weakened over subsequent days 3

Clinical Implication

While 30 cm H₂O remains the guideline-recommended maximum, clinicians should aim for plateau pressures below 27-29 cm H₂O when feasible, especially during the first 24-72 hours of mechanical ventilation 3, 4.

Relationship to Driving Pressure

Driving pressure (ΔP = plateau pressure - PEEP) has emerged as an important predictor of outcomes. However, comparative analyses show that plateau pressure provides slightly better prediction of mortality than driving pressure alone in patients receiving standardized lung-protective ventilation 4.

Practical approach:

  • Monitor both plateau pressure and driving pressure
  • Prioritize keeping plateau pressure ≤30 cm H₂O (strong evidence)
  • Simultaneously aim for driving pressure <15-19 cm H₂O when possible
  • Plateau pressure cut-off of 29 cm H₂O showed incremental mortality risk above this threshold 4

Measurement Technique

To accurately measure plateau pressure:

  1. Ensure patient is not actively breathing (may require sedation ± neuromuscular blockade)
  2. Apply inspiratory hold for 0.5-1 second at end-inspiration
  3. Read the pressure when it plateaus (typically within 0.5 seconds)
  4. Measure at least once daily, or more frequently when adjusting ventilator settings

Common Pitfalls

  • Patient-ventilator dyssynchrony: Active breathing efforts invalidate plateau pressure measurements
  • Insufficient inspiratory pause: Too brief a pause may not capture true plateau
  • Ignoring chest wall compliance: In patients with reduced chest wall compliance (obesity, abdominal compartment syndrome, chest wall edema), elevated plateau pressures may not reflect excessive lung distension—transpulmonary pressure measurement may be needed in these cases
  • Focusing solely on tidal volume: Plateau pressure must be monitored independently, as the same tidal volume can produce different plateau pressures depending on lung compliance

Integration with Lung-Protective Ventilation Strategy

Plateau pressure limitation is one component of the comprehensive lung-protective approach for ARDS 2, 1:

  • Tidal volume: 4-8 mL/kg predicted body weight (target 6 mL/kg)
  • Plateau pressure: ≤30 cm H₂O
  • PEEP: Higher PEEP strategies for moderate-severe ARDS (conditional recommendation)
  • Prone positioning: >12 hours/day for severe ARDS (strong recommendation)
  • Avoid prolonged recruitment maneuvers (strong recommendation against) 2

When plateau pressure exceeds 30 cm H₂O, reduce tidal volume in 1 mL/kg decrements (minimum 4 mL/kg) to achieve the target, accepting permissive hypercapnia if necessary 1.

References

Related Questions

What is the appropriate inspiratory-to-expiratory (I:E) ratio for patients with acute respiratory distress syndrome (ARDS)?
What is hysteresis in the pressure‑volume loop of acute respiratory distress syndrome (ARDS)?
What is the appropriate management for a patient who is visibly using accessory muscles to breathe, indicating acute respiratory distress?
What is the appropriate management of acute respiratory distress in an adult patient?
What is the appropriate management of acidosis in an adult with acute respiratory distress syndrome?
What are the differences between n‑butyl cyanoacrylate and 2‑octyl cyanoacrylate adhesives, and is either of them the same as Dermabond (2‑octyl cyanoacrylate), given prior skin reactions to Dermabond?
In a patient taking rosuvastatin 40 mg whose total cholesterol exceeds 200 mg/dL and low‑density lipoprotein cholesterol exceeds 125 mg/dL and who needs LDL‑C below 70 mg/dL, what additional medication should be added?
What is the recommended use of patient‑controlled analgesia (PCA) pumps for managing acute vaso‑occlusive pain in adolescents and adults with sickle cell disease, including opioid choice, dosing settings, monitoring, and alternative options?
What does an oxygen saturation of 84% during a six‑minute walk test indicate when the patient is not experiencing dyspnea?
What are the prescribing instructions for Latisse (bimatoprost ophthalmic solution 0.03%)?
Will a 3 mL bottle of Latisse (bimatoprost ophthalmic solution) last a full 30‑day month with the standard dosing of one drop per upper eyelid nightly?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.